Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. by Greenhalf, W, Ghaneh, P, Neoptolemos, J, Palmer, D, Cox, T, Lamb, R, Garner, E, Campbell, F, Mackey, JR, Costello, E, Moore, M, Valle, J, McDonald, A, Carter, R, Tebbutt, N, Goldstein, D, Shannon, J, Dervenis, C, Glimelius, B, Deakin, M, Charnley, R, Lacaine, F, Scarfe, A, Middleton, MR, Anthoney, A